{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:53:24Z","timestamp":1787018004138,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[1999,1]]},"abstract":"<jats:p>\n                    <jats:italic>Abstract<\/jats:italic>\n                    \u2014Salt sensitivity is a common trait in patients with essential hypertension and seems to have both an inherited and an acquired component (eg, is influenced by aging and renal insufficiency). Experimental evidence suggests that salt loading induces hypertension via a neurogenic mechanism mediated by the \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    -adrenergic receptors (\u03b1\n                    <jats:sub>2<\/jats:sub>\n                    -AR). To explore the \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    -AR subtype involved in this mechanism, we studied 2 groups of mice genetically engineered to be deficient in one of the 3 \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    -AR subtype genes (either \u03b1\n                    <jats:sub>2B<\/jats:sub>\n                    -AR +\/\u2212 or \u03b1\n                    <jats:sub>2C<\/jats:sub>\n                    -AR \u2212\/\u2212 knockout mice) compared with their wild-type counterparts. The mice (n=10 to 14 in each group) were submitted to subtotal nephrectomy and given 1% saline as drinking water for up to 35 days. Blood pressure (BP) was monitored by tail-cuff readings and confirmed at the end point by direct intra-arterial BP recording. The \u03b1\n                    <jats:sub>2B<\/jats:sub>\n                    -AR\u2013deficient mice had an attenuated BP response in this protocol (baseline 101.8\u00b12.7 versus end point 109.9\u00b12.8 mm Hg), whereas the BP of their wild-type counterparts went from a baseline 101.9\u00b12.3 to an end point 141.4\u00b17.1 mm Hg. The other 2 groups had BP increases of 44.6\u00b15.17 and 46.7\u00b17.01 mm Hg, with no difference between the mice deficient in the \u03b1\n                    <jats:sub>2C<\/jats:sub>\n                    -AR gene subtype versus their wild-type counterparts. Body weight, renal remnant weight, and residual renal function were no different among groups. These data suggest that a full complement of \u03b1\n                    <jats:sub>2B<\/jats:sub>\n                    -AR genes is necessary to raise BP in response to dietary salt loading, whereas complete absence of the \u03b1\n                    <jats:sub>2C<\/jats:sub>\n                    -AR subtype does not preclude salt-induced BP elevation. It is unclear whether the mechanism(s) involved in this process are of central origin (inability to increase sympathetic outflow), vascular origin (inability to vasoconstrict), or renal origin (inability to retain excess salt and fluid).\n                  <\/jats:p>","DOI":"10.1161\/01.hyp.33.1.14","type":"journal-article","created":{"date-parts":[[2012,6,11]],"date-time":"2012-06-11T20:53:46Z","timestamp":1339448026000},"page":"14-17","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":81,"title":["Role of the \u03b1\n                    <sub>2B<\/sub>\n                    -Adrenergic Receptor in the Development of Salt-Induced Hypertension"],"prefix":"10.1161","volume":"33","author":[{"given":"Konstantinos P.","family":"Makaritsis","sequence":"first","affiliation":[{"name":"From the Hypertension and Atherosclerosis Section of the Department of Medicine, Boston University School of Medicine, Boston, Mass; and Stanford University (B.K.), Stanford, Calif."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Handy","sequence":"additional","affiliation":[{"name":"From the Hypertension and Atherosclerosis Section of the Department of Medicine, Boston University School of Medicine, Boston, Mass; and Stanford University (B.K.), Stanford, Calif."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrado","family":"Johns","sequence":"additional","affiliation":[{"name":"From the Hypertension and Atherosclerosis Section of the Department of Medicine, Boston University School of Medicine, Boston, Mass; and Stanford University (B.K.), Stanford, Calif."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kobilka","sequence":"additional","affiliation":[{"name":"From the Hypertension and Atherosclerosis Section of the Department of Medicine, Boston University School of Medicine, Boston, Mass; and Stanford University (B.K.), Stanford, Calif."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gavras","sequence":"additional","affiliation":[{"name":"From the Hypertension and Atherosclerosis Section of the Department of Medicine, Boston University School of Medicine, Boston, Mass; and Stanford University (B.K.), Stanford, Calif."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haralambos","family":"Gavras","sequence":"additional","affiliation":[{"name":"From the Hypertension and Atherosclerosis Section of the Department of Medicine, Boston University School of Medicine, Boston, Mass; and Stanford University (B.K.), Stanford, Calif."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"crossref","unstructured":"Weinberger MH Miller JZ Luft FC Grim CE Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8(suppl II):II-127\u2013II-134.","DOI":"10.1161\/01.HYP.8.6_Pt_2.II127"},{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Oparil S Meng QC Chen YF Yang RH Jin H Wyss JM. Genetic basis of NaCl-sensitive hypertension. J Cardiovasc Pharmacol. 1988;12(suppl 3):S56\u2013S69.","DOI":"10.1097\/00005344-198800120-00009"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198908000-00001"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198612000-00006"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.11.4.326"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)90751-2"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.8.1.83"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0026-895X(25)13527-X","volume":"14","year":"1978","unstructured":"Tsai BS, Lefkowitz J. Agonist-specific effects of monovalent and divalent cations on adenylate cyclase-coupled alpha adrenergic receptors in rabbit platelets. Mol Pharmacol. 1978;14:540.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198506000-00012"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0026-895X(25)10044-8","volume":"48","year":"1995","unstructured":"Link RE, Stevens MS, Kulatunga M, Scheinin M, Barsh GS, Kobilka BK. Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homology. Mol Pharmacol. 1995;48:48\u201355.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5276.803"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.28.6.1064"},{"key":"e_1_3_2_13_2","first-page":"654","volume":"69","year":"1960","unstructured":"Koletsky S, Goodsitt AM. Natural history and pathogenesis of renal ablation hypertension. Arch Pathol. 1960;69:654\u2013662.","journal-title":"Arch Pathol"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(83)90306-5"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-198804000-00024"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5276.801"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.27.3.449"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(97)90625-8"},{"key":"e_1_3_2_19_2","unstructured":"Gavras H Handy D Gavras I. Alpha-adrenergic receptors in hypertension. In: Laragh JH Brenner BM eds. Hypertension Pathophysiology Diagnosis and Management. 2nd ed. New York: Raven Press; 1995:853\u2013861."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.9.1.3"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0022-3565(25)22634-9","volume":"245","year":"1988","unstructured":"Bylund DB, Ray-Prenger C, Murphy TJ. Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J Pharmacol Exp Ther. 1988;245:600\u2013607.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_22_2","first-page":"819","volume":"4","year":"1982","unstructured":"Pettinger WA, Gandler T, Sanchez A, Saavedra JM. Dietary sodium and renal alpha 2-adrenergic receptors in Dahl hypertensive rat. Clin Exp Hypertens A. 1982;4:819\u2013828.","journal-title":"A"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000138262"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90444-5"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(95)00024-J"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.27.6.1210"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","unstructured":"Bursztyn M Bresnahan M Gavras I Gavras H. Pressor hormones in elderly hypertensive persons. Racial differences. Hypertension. 1990;5(suppl I):I-88\u2013I-92.","DOI":"10.1161\/01.HYP.15.2_Suppl.I88"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.33.1.14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T17:42:29Z","timestamp":1743356549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.33.1.14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["10.1161\/01.HYP.33.1.14"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.33.1.14","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]},"assertion":[{"value":"1998-08-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-10-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}